etoposide has been researched along with Cardiomyopathies in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Farina, K; Kalac, M; Kim, S | 1 |
Gietema, JA; Hoekstra, HJ; Nuver, J; Sleijfer, DT; Sluiter, WJ; Smit, AJ; van den Berg, MP; van der Meer, J; van Gessel, AI; van Roon, AM | 1 |
Ahmann, DL; Decker, DA; Eagan, RT; Hahn, RG; Ingle, JN; Rubin, J | 1 |
Mizuta, K; Okuma, M; Sawada, H; Sawai, H; Takeda, Y; Tashima, M; Toi, T | 1 |
Chabner, BA; Cheson, BD; Fojo, A; Gutierrez, M; Jaffe, ES; Pearson, D; Steinberg, SM; Wilson, WH | 1 |
Blume, KG; Hoppe, RT; Horning, SJ; Hu, WW; Johnston, LJ; Negrin, RS; Stockerl-Goldstein, KE | 1 |
2 trial(s) available for etoposide and Cardiomyopathies
Article | Year |
---|---|
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer.
Topics: Bone Marrow; Breast Neoplasms; Cardiomyopathies; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Podophyllotoxin; Remission, Spontaneous; Time Factors | 1980 |
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Stroke Volume; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
4 other study(ies) available for etoposide and Cardiomyopathies
Article | Year |
---|---|
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Vincristine | 2021 |
Left ventricular and cardiac autonomic function in survivors of testicular cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autonomic Nervous System Diseases; Baroreflex; Bleomycin; Blood Pressure; Cardiomyopathies; Cisplatin; Echocardiography, Doppler; Etoposide; Humans; Male; Middle Aged; Orchiectomy; Testicular Neoplasms; Ventricular Dysfunction, Left | 2005 |
[Ischemic hepatitis due to anthracycline-induced cardiac insufficiency in a patient with acute myelocytic leukemia (M0)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis; Humans; Ischemia; Leukemia, Myeloid, Acute; Liver; Remission Induction | 1995 |
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Purging; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Cystitis; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infections; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |